INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,244 Cr | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,244 Cr |
| Mar2025 | ₹1,081 Cr |
| Mar2024 | ₹926 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹411 Cr |
How is Revenue of INNOVA CAPTAB Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,244 Cr | 15.02 | |
| Mar2025 | ₹1,081 Cr | 16.72 | |
| Mar2024 | ₹926 Cr | 15.72 | |
| Mar2023 | ₹801 Cr | 94.94 | |
| Mar2022 | ₹411 Cr | - | |
Compare Revenue of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹6,010.0 Cr | 5.3% | -18.2% | 32% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 5.3% |
-18.2% |
32% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses